PROTEOM

chemicals for use in the manufacture of pharmaceuticals, cosmetics, and healthcare products; chemicals for use in science, namely, reagents for scientific research; chemicals for use in biotechnology and chemicals produced through biotechnological processes, namely, vaccines, therapeutic proteins and biologics; peptides and polypeptides and small molecules for use in scientific research; all of the aforesaid for use in assays, screens and diagnosis

pharmaceutical preparations for therapeutic, prophylactic and/or pharmacological purposes, namely, for use in relation to abdominal disease,abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease, degeneration, dermatological disease, dystrophy, ear, nose, throat disease,endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder,genitourinary disease, growth disorder, hematological disease, immune disorder,immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological,mental and cognitive disorder, nutritional disorder, ocular disease, pain,pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder,somatosensory disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility; pharmaceutical preparations comprised of peptides and polypeptides for use in relation to abdominal disease, abnormal substrate concentration, asthenia, atrophy, breast disease, cardiovascular disease,degeneration, dermatological disease, dystrophy, ear, nose, throat disease,endocrine disease, fatigue, gastro-intestinal disorder, genetic disorder,genitourinary disease, growth disorder, hematological disease, immune disorder,immunomodulation, infection, inflammation, injury, metabolic disorder, mouth disease, movement disorder, musculoskeletal disease, neoplasm, neurological,mental and cognitive disorder, nutritional disorder, ocular disease, pain,pregnancy disorder, prophylaxis, renal disease, respiratory disease, sleep disorder,comatose disorder, temperature disorder, toxicity and intoxication, ulcer,uterine motility

computer hardware; data processors; computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; computer software for the design and identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; computer software comprised of algorithms for use in analysis and data-mining of sequence chemical databases

providing temporary use of online non-downloadable computer software for use in the design or identification and characterization of genes and proteins through bioinformatics and related techniques; providing temporary use of online non-downloadable software for the design or identification of chemical entities for drug discovery research; computer software for use in gene therapy and disease diagnosis; providing temporary use of online non-downloadable computer software comprised of algorithms for use in analysis and data-mining of sequence and chemical databases; providing databases and online databases featuring complementary peptide sequences to all known genes in the human, bacterial,viral, animal and plant genomes; proteomic, genomic, bioinformatics, chemical and scientific consultation services, namely, providing advice and consultation in the fields of genomics, informatics, study of protein properties molecular design;medical, scientific and biotechnological research, namely, identification and characterization of genes and proteins and the design or identification of chemical entities through bioinformatics and related techniques, and providing consultancy and advisory services relating thereto; consultancy, advice and provision of information relating to drug discovery research, disease diagnosis; design,creation and provision of databases, namely, databases for the identification and characterization of genes, proteins and small molecules; design and creation of computer software for data-mining; design, creation and development of proprietary informatics technology, namely for the location and definition of peptide and small molecule ligands; use of bioinformatics and related techniques to design the core regions of molecular functionality and to enable the generation,design, development and validation of peptide and small molecule ligands for existing and novel targets; prediction and design of peptides from DNA sequence data; data-mining operations; scientific research, namely, identification of targets for therapeutic applications and design of chemical inhibitors, agonists and antagonists; design, optimization and development of chemical inhibitors,agonists and antagonists for specific targets for therapeutic applications; design,creation and provision of informatics based programs designed to monitor and research scientific databases and identify potential leads matched to a companydiscovery portfolio; genetic research services, namely, obtaining and analyzing genetic or chemical information; gene sequencing; laboratory research and collaboration with academic research groups in the field of drug discovery and healthcare research; pharmaceutical and biotechnical research, namely,collaboration with pharmaceutical and biotechnology companies; drug discovery and development programs; synthesis of peptides and small molecules